Abstract The British Columbia Ministry of Health has renewed ties with Dr. Malcolm Maclure,
the BC Aca-demic Chair in Patient Safety and a pro-fessor at the University of BC, who was …

The Institute of Medicine (IOM) was engaged by the US Food and Drug Administration (FDA)
to investigate drug safety in the US and what the Agency could do to improve it. A corollary …

The IOM committee assessed the US drug-safety system and identified a number of serious
problems, including a lack of clear regulatory authority, chronic underfunding, organizational …

Improved access to postmarket drug data, a better understanding of how patients use
unapproved drugs and stronger risk assessment capabilities are needed within the United …

News refused to provide... particulars of the allegations being made against her.”
Warburton's wording closely resembles that in a suit filed last September by Malcolm …

CDER that would impede the agency's efforts to improve its drug safety system. But
Vaughan charged that “the thought that an independent or higherprofile office can't talk to …

News impact of drugs on patients.“Governments have walked away from drug development
and left this to the commercial sector,” he said. But by promoting data linkage and drug …

“There are lots of areas for improvement, but safety is the flagship” of the health care
enterprise, CMS Administrator Donald Berwick told conference attendees.“We will be seeing …

I n August 1992 the General Council of the CMA passed a resolution outlining a concern
with the growing number of drug names that look or sound alike. The resolution asked the …

Health Canada takes too long to assess and publicly communicate on potential safety
issues with pharmaceuticals once they are on the market, according to the annual fall report …